Preview

Артериальная гипертензия

Расширенный поиск

Синдром обструктивного апноэ во сне как медико-социальная проблема

Полный текст:

Аннотация

В статье приводятся литературные и собственные данные о распространенности синдрома апноэ во сне, негативном влиянии нарушений дыхания во сне на сердечно-сосудистую систему. Рассмотрены некоторые механизмы реализации неблагоприятного воздействия синдрома апноэ во сне на сердечно-сосудистую заболеваемость и смертность, а также приведены наиболее эффективные способы лечения нарушений дыхания но сне.

Об авторах

Ю. В. Свиряев
ФГУ «Федеральный центр сердца, крови и эндокринологии им. В.А. Алмазова Росмедтехнологий»
Россия


Л. С. Коростовцева
ФГУ «Федеральный центр сердца, крови и эндокринологии им. В.А. Алмазова Росмедтехнологий»
Россия


Н. Э. Звартау
ФГУ «Федеральный центр сердца, крови и эндокринологии им. В.А. Алмазова Росмедтехнологий»
Россия


О. П. Ротарь
ФГУ «Федеральный центр сердца, крови и эндокринологии им. В.А. Алмазова Росмедтехнологий»
Россия


К. Т. Киталаева
ФГУ «Федеральный центр сердца, крови и эндокринологии им. В.А. Алмазова Росмедтехнологий»
Россия


А. Л. Калинкин

Россия


А. О. Конради
ФГУ «Федеральный центр сердца, крови и эндокринологии им. В.А. Алмазова Росмедтехнологий»
Россия


Список литературы

1. Ковальзон В.М. Природа сна. Природа. - 1998. № 8. - С. 172-179.

2. Вейн A.M. Синдром апноэ во сне и другие расстройства дыхания, связанные со сном: клиника, диагностика, лечение. М.: 2002.

3. Lugaresi E., Berti Ceroni G., Pazzaglia P. Some criteria for the definition of normal sleep in man. Riv Sper Freniatr Med Leg Alien Ment 1969; 93 (3): 610-631.

4. Пэрн Н.Я. «Сон и его значение», Петроград, 1923.

5. Lavie P. Who was the first to use the term Pickwickian in connection with sleepy patients? History of sleep apnoea syndrome. Sleep Med Rev. 2008; 12 (1): 5-17.

6. Gastaut H., Tassinari C.A., Duron B. Polygraphic study of diurnal and nocturnal (hypnic and respiratory) episodal manifestations of Pickwick syndrome. Rev Neurol (Paris). 1965, 112 (6): 568-79.

7. Вейн A.M. Синдром апноэ во сне и другие расстройства дыхания, связанные со сном: клиника, диагностика, лечение. М.: 2002.

8. Lavie P. Who was the first to use the term Pickwickian in connection with sleepy patients? History of sleep apnoea syndrome. Sleep Med Rev. 2008; 12 (1): 5-17.

9. Terry Young, Mari Palta, Jerome Dempsey, James Skatrud, Steven Weber, and Safwan Badr. The Occurrence of Sleep-Disordered Breathing among Middle-Aged Adults. The New Eng J Med. 1993; 328 (17): 1230-1235.

10. Young T., Peppard P.E., Gottlieb D.J. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med. 2002; 105 (9): 1217- 1239.

11. Ротарь O.П., Свиряев Ю.В., Звартау Н.Э. и др. Распространенность синдрома апноэ/гипопноэ во сне среди пациентов с сердечно-сосудистой патологией. Бюлл. научн.-исслед. ин-та кардиологии им. В.А. Алмазова. - 2004. - Т. II, № 1. - С. 91-94.

12. Marin J.M., Carrizo S.J., Vicente E., Agusti A.G. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet. 2005; 365 (9464): 1046-1053.

13. Mehra R., Benjamin E.J., Shahar E., Gottlieb D.J., Nawabit R., Kirchner H.L., Sahadevan J., Redline S.: Sleep Heart Health Study. Association of nocturnal arrhythmias with sleep-disordered breathing: The Sleep Heart Health Study. Am J Respir Crit Care Med. 2006: 173 (8): 910-916.

14. Guidelines for the management of arterial hypertension. Eur. H. J. 2007. 28.: 1462-1536.

15. Lattimore J.D., Celermajer D.S., Wilcox I. Obstructive sleep apnea and cardiovascular disease. J Am Coll Cardiol. 2003; 41 (9): 1429-37.

16. Peker Y., Carlson J., Hedner J. Increased incidence of coronary artery disease in sleep apnoea: a long-term follow-up. Eur Respir J. 2006; 28 (3): 596-602.

17. Neau J.P., Paquereau J., Mcurice J.C., Chavagnat J.J., Gil R. Stroke and sleep apnoea: cause or consequence? Sleep Med Rev. 2002; 6 (6):457-69.

18. Shepard J.W., Thawley S.E. Localization of upper airway collapse during sleep in patients with obstructive sleep apnea. Am. Rev. Respir. Dis. - 1990, - V. 141. - P. 1350-1355;

19. Hudgel D.W. Mechanisms of obstructive sleep apnea Chest. 1992:101: 541-549;

20. Bonsignore M.R., Marrone O., Insalaco G. et al. The cardiovascular effects of obstructive sleep apnoeas: analysis of pathogenic mechanisms. Eur. Respir. J 1994: 17: 786-805.

21. Sullivan C.E., Issa F.G. Obstructive sleep apnea. Clin. Chest Med 1985; 6: 633-650.

22. Strollo P.J. Jr, Rogers R.M. Obstructive sleep apnea. N Engl J Med. 1996; 334 (2): 99-104.

23. Parker J. et al. Acute and chronic effects of airway obstruction on canine left ventricular performance. Am. J. Respir. Crit. Care Med. 1999; 160: 1888-1896.

24. Tkacova R., Rankin F., Fitzgerald P., Floras J., Bradley T. Effects of continuos positive airway pressure on obstructive sleep apnea and left ventricular afterload in patients with heart failure. Circulation. 1998; 98: 2269-2275.

25. Somers V., Dyken M., Clary M., Abbuod F. Sympathetic neural mechanisms in obstructive sleep apnea. J. Clin. Invest. - 1995. - Vol. 96. - P. 1897-1904;

26. Olmetti F., La Rovere M.T., Robbi E., Tatirino A.H., Fanfulla F. Nocturnal cardiac arrhythmia in patients with obstructive sleep apnea. Sleep Med. 2007 Nov 15; [Eptlb ahead of print].

27. Osanai S., Akiba Y., Fujiuchi S., Nakano H., Matsumoto H., Ohsaki Y., Kikuchi K. Depression of peripheral chemosensitivity by a dopaminergic mechanism in patients with obstructive sleep apnoea syndrome. Eur Respir J. 1999; 13 (2): 418-423.

28. Mahamed S., Hanly P.J., Gabor J., Beecroft J., Duffin J. Overnight changes of chemoreflex control in obstructive sleep apnoea patients. Respir Physiol Neurobiol. 2005: 116 (2-3): 279-290.

29. Narkiewicz K., Pesek C.A., Kato M., Phillips B.G., Davison D.E., Somers V.K. Baroreflex control of sympathetic nerve activity and heart rate in obstructive sleep apnea. Hypertension. 1998: 32 (6): 1039-1043.

30. Ziegler M.G., Mills P.J., Loredo J.S., Ancoli-Israel S., Dimsdale J.E. Effect of continuous positive airway pressure and placebo treatment on sympathetic nervous activity in patients with obstructive sleep apnea. Chest. 2001; 120 (3): 887-893.

31. Звартау Н.Э. Метаболические и нейрогуморальные изменения у больных с ожирением, артериальной гипертензией и синдромом обструктивного апноэ/гипопноэ во сне. Автореф. лис. - 2005. - с. 18.

32. Foster G.E., Poulin M.J., Hardy P.J. Intermittent hypoxia and vascular function: implications for obstructive sleep apnoea. Exp Physiol. 2007: 92 (1 ): 51-65.

33. Shamsuzzaman A.S., Gersh B.J., Somers V.K. Obstructive sleep apnea: implications for cardiac and vascular disease. JAMA. 2003; 290 ( 14): 1906-1914.

34. Bonanni E., Pasquali L., Manca M.L., Maestri M., Prontera C., Fabbrini M., Berrettini S., Zucchelli G., Siciliano G., Murri L. Lactate production and catecholamine profile during aerobic exercise in normotensive OSAS patients. Sleep Med. 2004; 5 (2): 137-145.

35. de Bruvne M.C., Hoes A.W., Kors J.A., Hofman A., van Bemmel J.H., Grobbee D.E. QTc dispersion predicts cardiac mortality in the elderly: the Rotterdam Study. Circulation. 1998; 97 (5): 467-72;

36. Makino S. Iwata M. Fujiwara M. Ike S. Tateyama 11. A case of sleep apnea syndrome manifesting severe hypertension with high plasma norepinephrine levels. Endocr J. 2006; 53 (3): 363-9.

37. Alonso-Fernandez A., Garcia-Rio F., Racionero M.A. Pino J.M., Ortuco F, Martinez I, Villamor J. Cardiac rhythm disturbances and ST-segment depression episodes in patients with obstructive sleep apnea-hypopnea syndrome and its mechanisms. Chest. 2005; 127 (1): 15-22.

38. Carlson J.T., Hedner J., Flam M., Ejnell M., Sellgren J., Wallin B.G. Augmented resting sympathetic activity in awake patients with obstructive sleep apnea. Chest. 1999; 103 (6): 1763 8;

39. Sukegawa M., Noda A., Sugiura T., Nakala S., Yoshizaki S., Soga T., Yasuda Y., Iwayama N., Nakai S., Koike Y. Assessment of continuous positive airway pressure treatment in obstructive sleep apnea syndrome using 24-hour urinary catecholamines. Clin Cardiol, 2005: 28 (11): 519-22.

40. Heitmaun J., Ehlenz K., Penzel T., Becker H.F., Grote L., Voigt K.H., Peter J.H. Vogelmeier C. Sympathetic activity is reduced by nCPAP in hypertensive obstructive sleep apnoea patients. Eur Respir J. 2004; 23 (2): 255-262.

41. Bralel T., Wennlund A., Carlstrom K. Pituitary reactivity, androgens and catecholamines in obstructive sleep apnoea. Effects of continuous positive airway pressure treatment (CPAP). Respir Med. 1999: 93 (1): 1-7.

42. Mills P.J., Kennedy B.P., Loredo J.S., Dimsdale J.E., Ziegler M.G. Effects of nasal continuous positive airway pressure and oxygen supplementation on norepinephrine kinetics and cardiovascular responses in obstructive sleep apnea. J Appl Physiol. 2006; 100 (1): 343-348.

43. Nakagawa Y., Kishida K., Kihara S., Sonoda M., Hirata A., Yasui A., Nishizawa H., Nakamura T., Yoshida R., Shimomura I., Funahashi T. Nocturnal reduction in circulating adiponectin concentrations related to hypoxic stress in severe obstructive sleep apnea hypopnea syndrome. Am J Physiol Endocrinol Metab. 2008. (Abstract).

44. Takahashi N., Anan F., Nakagawa M., Yufu K., Shinohara T., Tsubone T,, Goto K., Masaki T., Katsuragi I., Tanaka K., Kakuma Т., Нага M., Saikawa T., Yoshimatsu H. Hypoadiponectinemia in type 2 diabetes mellitus in men is associated with sympathetic overactivity as evaluated by cardiac 1231-inelaiodobenzylguanidine scintigraphy. Metabolism. 2007; 56 (7): 919-924.

45. Sumi K., Chin K., Takahashi K., Nakamura T., Matsumoto H., Niimi A., Mishima M. Effect of nCPAP therapy on heart rate in patients with obstructive sleep apnoea-hypopnoea. JM. 2006; 99 (8): 545-553.

46. Kazumi T., Kawaguchi A., Hirano T., Yoshino G. Serum adiponectin is associated with high-density lipoprotein cholesterol. triglycerides, and low-density lipoprotein particle size in young healthy men. Metabolism. 2001; 53 (5): 589-593.

47. Wolk R., Svatikova A., Nelson C.A., Garni A.S., Govender K., Winnicki M., Somers V.K. Plasma levels of adiponectin, a novel adipocyte-derived hormone, in sleep apnea. Obes Res. 200513 (1): 186-190.

48. Aydin M., Altin R., Ozeren A., Kart L., Bilge M., Unalacak M. Cardiac autonomic activity in obstructive sleep apnea: time-dependent and spectral analysis of heart rate variability using 24-hour Holter electrocardiograms. Tex Heart Inst J. 2004; 31 (2): 132-136.

49. Koskenvuo M., Kaprio J., Partinen M. et al. Snoring as a risk factor for hypertension and angina pectoris. Lancet 1985: 1: 893-896.

50. Kales A., Cadieuw R.G. et al. Sleep apnea in a hypertensive population. Lancet. 1984: 2: 1005-1008.

51. Fletcher E.G., DeBehnke R.D., Lovoi M.S. et al. Undiagnosed sleep apnea in patients with essential hypertension. Ann. Intern. Med. 1985: 103: 190-195.

52. Kimoff R.J., Brooks D., Horner R.L., Kozar L.F. Render-Teixeira C.L., Champagne V., Mayer P., Phillipson E.A. Ventilatory and arousal responses to hypoxia and hypcicapnia in a canine model of obstructive sleep apnea. Am J Respir Crit Care Med. 1997: 56 (3 Pt 1):886-94.

53. Davies C.W., Crosby J.H., Mullins R.L. et al. Case-control study of 24hour ambulatory blood pressure in patients with obstructive sleep apnea and normal matched control subjects. Thorax. 2000: 55: 73-740.

54. Nieto F.J., Young T.B., Lind B.K. et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study: Sleep Heart Health Study // JAMA. 2000: 283: 1829-1836.

55. Baruzzi A., Riva R., Cirignotta F., Zucconi M., Cappelli M., Lugaresi F. Atrial natriuretic peptide and catecholamines in obstructive sleep apnea syndrome. Sleep. 1991: 14 (1): 83-86.

56. Lin C.C., Tsan К.W., Lin C.Y. Plasma levels of at rial natriuretic factor in moderate to severe obstructive sleep apnea syndrome. Sleep. 1993: 16 (1): 37-39.

57. Kita H., Ohi M., Chin K., Noguchi T., Otsuka N., Tsuboi T., Itoh H., Nakao K., Kuno K. The nocturnal secretion of cardiac natriuretic peptides during obstructive sleep apnoea and its response to therapy with nasal continuous positive airway pressure. J Sleep Res. 1998: 7 (3): 199-207.

58. Tasci S., Manka R., Scholtyssek S., Lentini S., Troatz C., Stoffel-Wagner B., Luderitz B. NT-pro-BNP in obstructive sleep apnea syndrome is decreased by nasal continuous positive airway pressure. Clin Res Cardiol. 2006; 95(1): 23-30.

59. Hudner R.H., El Mokhtari N.E., Freitag S., Rausche T., Goder R., Tiroke A., Lins M., Simon R., Bewig B. NT-proBNP is not elevated in patients with obstructive sleep apnoea. Respir Med. 2008: 102 (1): 134-142.

60. Maeder M.T., Ammann P., Rickli H., Schoch O.D., Korte W., Hurny C., Myers J., Munzer T. N-terminal pro-B-type natriuretic peptide and functional capacity in patients with obstructive sleep apnea. Sleep Breath. 2008; 12 (1): 7-16.

61. Vartany F., Imevbore M., O'Malley M., Manfredi C., Pasquarella C., Scinto L., Fine J. N-terminal pro-brain natriuretic peptide for detection of cardiovascular stress in patients with obstructive sleep apnea syndrome. J Sleep Res. 2006; 15 (4): 424-429.

62. Foster G.E., Poulin M.J., Hanly P.J. Intermittent hypoxia and vascular function: implications for obstructive sleep apnoea. Exp Physiol. 2007: 92 (1): 51-65.

63. Mills P.J., Dimsdale J.E. Sleep apnea: a model for studying cytokines, sleep, and sleep disruption. Brain Behav Immun. 2004: 18 (4): 298-303.

64. Berg A.H., Scherer P.E. Adipose tissue, inflammation, and cardiovascular disease. Circ Res. 2005: 96 (9): 939-949.

65. Lau D.C., Dhillon B., Yan H., Szmitko P.E., Verma S. Adipokines: molecular links between obesity and atheroslcerosis. Am J Physiol Heart Circ Physiol. 2005:288 (5): H2031 -204.

66. Lavie L., Perelman A., Lavie P. Plasma homocysteine levels in obstructive sleep apnea: association wit h cardiovascular morbidity. Chest. 2001:120 (3): 900-908.

67. Can M., Acikgoz S., Mungan G., Bayraktaroplu Т., Kocak E., Guven B., Demirtas S. Serum cardiovascular risk (actors in obstructive sleep apnea. Chest. 2006 Feb;129(2):233-237.

68. Jordan W, Berger C, Cohrs S. Rodenbeck A, Mayer G, Niedmann P.D, von Alisen N., Ruther F., Kornhuber J., Bleich S. СPAP-therapy effectively lowers serum homocysteine in obstructive sleep apnea syndrome. J Neural Transm. 2004: 111 (6): 683-689.

69. Rubinsztajn R., Kumor M., Byskiniewicz K., Chazan R. The influence of 3 weeks therapy with continuous positive airway pressure on serum leptin and homocysteine concentration in patients with obstructive sleep apnea syndrome. Pneumonol Alergol Pol. 2006; 74 (1): 63-7.

70. Svatikova A., Wolk R., Magera M.J., Shamsuzzaman A.S., Phillips B.G., Somers V.K. Plasma homocysteine in obstructive sleep apnoea. Fur Mean J. 2004; 25(15): 1325-1239.

71. Spicuzza L., Bernardi L., Calciati A., Di Maria G.U. Autonomic modulation of heart rate during obstructive versus central apneas in patients with sleep-disordered breathing. Am J Respir Crit Care Med. 2003: 167 (6): 902-910.

72. Hanly P.J., George C.F., Millar T.W., Kryger M.H. Heart rate response to breath-hold, valsalva and Mueller maneuvers in obstructive sleep apnea. Chest. 1989; 95 (4): 735-739.

73. Spicuzza L., Bernardi L., Calciati A., Di Maria G.U. Autonomic modulation of heart rate during obstructive versus central apneas in patients with sleep-disordered breathing. Am J Respir Crit Care Med. 2003; 167 (6): 902-910.

74. Guilleminault C., Connolly S.J., Winkle R.A. Cardiac arrhythmia and conduction disturbances during sleep in 400 patients with sleep apnea syndrome. Am J Cardiol. 1983; 52 (5): 490-494.

75. Shepard J.W. Jr. Cardiopulmonary consequences of Obstructive sleep apnea. Mayo Clin Proc. 1990: 65 (9): 1250-9

76. Tafil-Klawe M., Thiele A.E., Raschke F., Mayer J,, Peter J,H., von Wichert W. Peripheral chemoreceptor reflex in obstructive sleep apnea patients; a relationship between ventilatory response to hypoxia and nocturnal bradycardia during apnea events. Pneumologie. 1991; 45Suppl 1: 309-11.

77. Zwillich C., Devlin T., White D., Douglas N., Weil J., Martin R. Bradycardia during sleep apnea. Characteristics and mechanism. J Clin Invest. 1982: 69 (6): 1286-1292.

78. Shepard J.W. Jr. Cardiopulmonary consequences of obstructive sleep apnea. Mayo Clin Proc. 1990 Sep; 65 (9): 1250-9.

79. Tilkian A.G., Guilleminault C., Schroeder J.S., Lehrman K.L., Simmons F.B., Dement W.C. Sleep-induced apnea syndrome. Prevalence of cardiac arrhythmias and their reversal alter tracheostomy. Am J Med. 1977 Sep; 63 (3): 348-58;

80. Simantirakis F.N., Schiza S.I., Marketou M.F., Chrvsostomakis S.I., Chlouverakis G.I., Klapsinos N.C., Siafakas N.S., Vardas P.E. Severe bradyarrhythmias in patients with sleep apnoea: the riled of continuous positive airway pressure treatment: a long-term evaluation using an insertable loop recorder. Fur Heart J. 2004: 25 (12): 1070-1076.

81. Grimm W., Hoffmann J., Kohler U., Heitmann J., Peter J.H., Von Wichert P., Maisch B. Invasive electrophysiological evaluation of patients with sleep apnoea-associated ventricular asystole-methods and preliminary results. J Sleep Res. 1995; 4 (S1): 160-165.

82. Madden B.P., Shenoy V., Dalrymple-Hay M., Griffiths T., Millard J., Backhouse L., Clarke J., Murday A. Absence of bradycardic response to apnea and hypoxia in heart transplant recipients with obstructive sleep apnea. J Heart Lung Transplant. 1997; 16 (4): 394-397.

83. Ryan S., Ward S., Heneghan C., McNicholas W.T. Predictors of decreased spontaneous baroreflex sensitivity in obstructive sleep apnea syndrome. Chest. 2007; 131 (4): 1100-1117.

84. Carlson J.T., Hedner J.A., Sellgren J., Elam M., Wallin B.G., Depressed baroreflex sensitivity in patients with obstructive sleep apnea. Am J Respir Crit Care Med. 1996 Nov; 154 (5): 1490-6.

85. Andreas S., Hajak G. von Breska B., Ruther E., Kreuzer H. Changes in heart rate during obstructive sleep apnoea. Eur Respir J. 1992 Jul; 5 (7): 853-7.

86. Findley L.J., Boykin M., Fallon T., Belardinelli L. Plasma adenosine and hypoxemia in patients with sleep apnea. J Appl Physiol. 1988 Feb; 64 (2): 556-561.

87. Ерошина В.А. Значение СОАС в развитии сердечно-сосудистых поражений. Автореф. дис. М. - 2000. - С. 42.

88. Shivalkar В., Van de Heyning С., Kerremans M., Rinkevich D., Verbraecken J., De Backer W., Vrints С Obstructive sleep apnea syndrome: more insights on structural and functional cardiac alterations, and the effects of treatment with continuous positive airway pressure. J Am Coll Cardiol. 2006: 47: 1433-1439.

89. Fung J.W., Li T.S., Choy D.K., Yip G.W., Ко F.W., Sanderson J.E., Hui D.S. Severe obstructive sleep apnea is associated with left ventricular diastolic dysfunction. Chest. 2002; 121 (2): 422-429.

90. Kanagala R., Murali N.S., Friedman P.A., Ammash N.M., Gersh B.J., Ballman K.V., Shamsuzzaman A.S., Somers V.K. Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation. 2003; 107 (20): 2589-2591.

91. Hedner J., Ejnell H., Caidahl K. Left ventricular hypertrophy independent of hypertension in patients with obstructive sleep apnea J. Hypertens. - 1990. - Vol. 8. - P. 941-946;

92. Noda A., Okada Т., Yasuma F., Nakashima N., Yokota M. Cardiac hypertrophy in obstructive sleep apnea syndrome. Chest. 1995; 107: 1538-1544.

93. Davies R., Crosby J., Prothero A., Stradling J. Ambulatory blood pressure and left ventricular hypertrophy in subjects with untreated obstructive sleep apnea and snoring compared with matched control subjects, and their response to treatment. Clin. Sci 1994; 86: 417-424.


Для цитирования:


Свиряев Ю.В., Коростовцева Л.С., Звартау Н.Э., Ротарь О.П., Киталаева К.Т., Калинкин А.Л., Конради А.О. Синдром обструктивного апноэ во сне как медико-социальная проблема. Артериальная гипертензия. 2008;14(1-S2):127-134.

For citation:


., ., ., ., ., ., . . "Arterial’naya Gipertenziya" ("Arterial Hypertension"). 2008;14(1-S2):127-134. (In Russ.)

Просмотров: 62


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 1607-419X (Print)
ISSN 2411-8524 (Online)